Immune Cells Are Differentially Affected by SARS-CoV-2 Viral Loads in K18-hACE2 Mice.
Jung Ah KimSung-Hee KimJeong Jin KimHyun Ah NohSu-Bin LeeHaengdueng JeongJiseon KimDonghun JeonJung Seon SeoDain OnSuhyeon YoonSang Gyu LeeYoun Woo LeeHui Jeong JangIn Ho ParkJooyeon OhSang-Hyuk SeokYu Jin LeeSeung-Min HongSe-Hee AnJoon-Yong BaeJung-Ah ChoiSeo Yeon KimYoung Been KimJi-Yeon HwangHyo-Jung LeeHong Bin KimDae-Gwin JeongDae-Sub SongMan Ki SongMan-Seong ParkKang-Seuk ChoiJun Won ParkJun-Won YunJeon-Soo ShinHo-Young LeeSin-Hyeog ImJun-Young SeoKi Taek NamHeon Yung GeeJe-Kyung SeongPublished in: Immune network (2024)
Viral load and the duration of viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are important determinants of the transmission of coronavirus disease 2019. In this study, we examined the effects of viral doses on the lung and spleen of K18-hACE2 transgenic mice by temporal histological and transcriptional analyses. Approximately, 1×10 5 plaque-forming units (PFU) of SARS-CoV-2 induced strong host responses in the lungs from 2 days post inoculation (dpi) which did not recover until the mice died, whereas responses to the virus were obvious at 5 days, recovering to the basal state by 14 dpi at 1×10 2 PFU. Further, flow cytometry showed that number of CD8+ T cells continuously increased in 1×10 2 PFU-virus-infected lungs from 2 dpi, but not in 1×10 5 PFU-virus-infected lungs. In spleens, responses to the virus were prominent from 2 dpi, and number of B cells was significantly decreased at 1×10 5 PFU; however, 1×10 2 PFU of virus induced very weak responses from 2 dpi which recovered by 10 dpi. Although the defense responses returned to normal and the mice survived, lung histology showed evidence of fibrosis, suggesting sequelae of SARS-CoV-2 infection. Our findings indicate that specific effectors of the immune response in the lung and spleen were either increased or depleted in response to doses of SARS-CoV-2. This study demonstrated that the response of local and systemic immune effectors to a viral infection varies with viral dose, which either exacerbates the severity of the infection or accelerates its elimination.